<DOC>
	<DOC>NCT00267215</DOC>
	<brief_summary>This trial assessed the safety and efficacy of a single dose of lumiracoxib 400 mg compared to placebo and to a single dose of celecoxib 200mg. It also assessed safety and efficacy of 400mg lumiracoxib administered once a day for 7 days compared to placebo and to 200 mg celecoxib twice daily.</brief_summary>
	<brief_title>Efficacy and Safety of Lumiracoxib</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Inclusion criteria: Osteoarthritis of the knee Pain intensity at baseline of at least 50mm on a 100mm visual analog scale Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Lumiracoxib</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>